C4 Therapeutics, Inc. (CCCC)
NASDAQ·Healthcare·Biotechnology
$3.05
-1.58%
Mkt Cap $381.38M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (11 analysts)
$11.33
Range $6.00 – $20.00
Implied Upside
+271.4%
Consensus $11.33 vs current $3.05
NASDAQ·Healthcare·Biotechnology
$3.05
-1.58%
Mkt Cap $381.38M
Buy
2
Hold
0
Sell
0
Price Target (11 analysts)
$11.33
Range $6.00 – $20.00
+271.4%
Consensus $11.33 vs current $3.05